FEASIBILITY STUDY, LICENSE AND OPTION AGREEMENTFeasibility Study, License and Option Agreement • December 19th, 2008 • Nitromed Inc • Pharmaceutical preparations • Delaware
This Feasibility Study, License and Option Agreement (this “Agreement”) is made effective as of August 31, 2008 (the “Effective Date”), by and between Archemix Corp, a Delaware corporation with offices at 300 Third Street, Cambridge, Massachusetts 02142 (“Archemix”), and Eli Lilly and Company, an Indiana corporation with a business address at Lilly Corporate Center, Indianapolis, Indiana 46285 (“Lilly”). Archemix and Lilly are each sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties.”
